Incyte : INCY

All Incyte Articles

136 Articles

Lee Jackson | Feb 20, 2016 at 10:10 AM EST

Massive Biotech Purchases Highlight Insider Buying: Incyte, TransDigm, Prospect Capital, Xenoport and More

Despite the market rally, insiders are still buying at big levels, while insider selling remains dormant. This is a very…

Chris Lange | Feb 13, 2016 at 10:15 AM EST

4 BioPharma Movers That Cannot Be Ignored

These biotech companies 24/7 Wall St. has picked stood out from the rest with big moves over the course of…

Chris Lange | Feb 11, 2016 at 9:15 AM EST

Incyte Underwhelms With Earnings

Incyte reported better-than-expectged fourth-quarter financial results after the markets closed on Wednesday.

Chris Lange | Jan 30, 2016 at 10:10 AM EST

Despite Target Cuts, Analysts Stick With Incyte for Big Upside

After the announcement that its Phase 2 trial of Ruxolitinib would be stopped a few analysts took a deeper look…

Jon C. Ogg | Jan 28, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: Boeing, eBay, Facebook, Incyte, Kinder Morgan, PayPal, Qualcomm, US Steel and More

Thursday's top analyst calls include Boeing, eBay, Facebook, Incyte, Kinder Morgan, PayPal, Qualcomm and U.S. Steel.

Chris Lange | Jan 20, 2016 at 11:45 AM EST

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Credit Suisse sees solid fundamentals, despite a harsh market landscape, for large-cap biotech firms. It initiated several top biotech stocks…

Jon C. Ogg | Jan 20, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More

Wednesday's top analyst calls include AMD, Amazon.com, Celgene, Comerica, Fortinet, Gilead Sciences, Lennar, Netflix, Voya and Wayfair.

Jon C. Ogg | Jan 6, 2016 at 8:40 AM EST

Top Analyst Upgrades and Downgrades: Bluebird Bio, Check Point, Comcast, Eli Lilly, Hyatt, Lockheed Martin, Rite Aid and Many More

The top analyst calls for Wednesday, January 6, 2016, include Bluebird Bio, Check Point Software, Comcast, Eli Lilly, Hyatt Hotels,…

Lee Jackson | Nov 16, 2015 at 8:40 AM EST

Hot Biotech Stocks Highlight Jefferies Top Growth Stocks to Buy This Week

This week the Jefferies analysts are positive on companies that took a shot price-wise last week and may be offering…

Lee Jackson | Oct 16, 2015 at 9:25 AM EDT

Big Biotech Is Cheap With Strong Cash Flows: 3 to Buy Before Earnings

These three top biotech names are very good bets for investors looking to add high-quality companies with less volatility and…

Lee Jackson | Oct 7, 2015 at 8:40 AM EDT

Why Merrill Lynch Now Favors Large Cap Leaders in Biotech

These four top large cap biotechs are very good bets for investors looking to add high-quality companies with less volatility…

Lee Jackson | Sep 11, 2015 at 8:20 AM EDT

Jefferies Starts Coverage on Biotechs: 3 Top Stocks to Buy Now

In a new and very comprehensive report, Jefferies starts coverage on biotechs with some very targeted stock selections.

Jon C. Ogg | Jun 8, 2015 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Exxon, Home Depot, Lululemon, 3M, Vodafone, Mondelez, Chevron and More

Monday's top analyst upgrades, downgrades and initiations include Exxon Mobil, Home Depot, Lululemon Athletica, 3M, Vodafone, Mondelez International and Chevron.

Lee Jackson | May 7, 2015 at 8:30 AM EDT

Why These 4 Biotech Stocks Could Be the Next Buyout Targets

A new research note from SunTrust Robinson Humphrey mentions four stocks that they think could possibly get swept up in…

Lee Jackson | Mar 6, 2015 at 8:20 AM EST

The Next 3 Likely Biotech Buyout Candidates

Here are three biotech stocks that a SunTrust analyst feels could be buyout candidates, in the wake of the Pharmacyclics…

1 … 4 5 6 7 8 … 10

Incyte : INCY

All Incyte Articles

Massive Biotech Purchases Highlight Insider Buying: Incyte, TransDigm, Prospect Capital, Xenoport and More

4 BioPharma Movers That Cannot Be Ignored

Incyte Underwhelms With Earnings

Despite Target Cuts, Analysts Stick With Incyte for Big Upside

Top Analyst Upgrades and Downgrades: Boeing, eBay, Facebook, Incyte, Kinder Morgan, PayPal, Qualcomm, US Steel and More

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More

Top Analyst Upgrades and Downgrades: Bluebird Bio, Check Point, Comcast, Eli Lilly, Hyatt, Lockheed Martin, Rite Aid and Many More

Hot Biotech Stocks Highlight Jefferies Top Growth Stocks to Buy This Week

Big Biotech Is Cheap With Strong Cash Flows: 3 to Buy Before Earnings

Why Merrill Lynch Now Favors Large Cap Leaders in Biotech

Jefferies Starts Coverage on Biotechs: 3 Top Stocks to Buy Now

Top Analyst Upgrades and Downgrades: Exxon, Home Depot, Lululemon, 3M, Vodafone, Mondelez, Chevron and More

Why These 4 Biotech Stocks Could Be the Next Buyout Targets

The Next 3 Likely Biotech Buyout Candidates

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Incyte : INCY

All Incyte Articles

Massive Biotech Purchases Highlight Insider Buying: Incyte, TransDigm, Prospect Capital, Xenoport and More

4 BioPharma Movers That Cannot Be Ignored

Incyte Underwhelms With Earnings

Despite Target Cuts, Analysts Stick With Incyte for Big Upside

Top Analyst Upgrades and Downgrades: Boeing, eBay, Facebook, Incyte, Kinder Morgan, PayPal, Qualcomm, US Steel and More

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More

Top Analyst Upgrades and Downgrades: Bluebird Bio, Check Point, Comcast, Eli Lilly, Hyatt, Lockheed Martin, Rite Aid and Many More

Hot Biotech Stocks Highlight Jefferies Top Growth Stocks to Buy This Week

Big Biotech Is Cheap With Strong Cash Flows: 3 to Buy Before Earnings

Why Merrill Lynch Now Favors Large Cap Leaders in Biotech

Jefferies Starts Coverage on Biotechs: 3 Top Stocks to Buy Now

Top Analyst Upgrades and Downgrades: Exxon, Home Depot, Lululemon, 3M, Vodafone, Mondelez, Chevron and More

Why These 4 Biotech Stocks Could Be the Next Buyout Targets

The Next 3 Likely Biotech Buyout Candidates

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

Turning $250K Into $1M in 5 Years: Why This Real Estate Promise Is a Red Flag

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do